Notes in 01_Myasthenia Gravis

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/10/2024	{{c1::Myasthenia gravis}} is {{c2::an autoimmune condition that produces auto-antibodies that affect the acetylcholine receptors in the neuromusc…
Published	02/10/2024	Presentation of {{c2::Myasthenia Gravis}} {{c1::Muscle weakness that worsens with activity and improves with rest}} {{c1::Ocular: weakness in the eyel…
Published	02/10/2024	Presentation of {{c2::Myasthenic Crisis}} {{c1::Acute respiratory failure (breathlessness, complete dysphagia)}} {{c1::History of myasthenia gravis}}
Published	02/10/2024	Antibodies diagnostic of {{c2::Myasthenia Gravis}} include {{c1::anti-AChR antibodies (90%)}} and {{c1::anti-muscle-specific kinase (MuSK) a…
Published	02/10/2024	{{c1::CT Chest}} is done in patients with Myasthenia Gravis to look for tumours of the {{c2::thymus gland}}
Published	02/10/2024	Symptomatic Treatment of Myasthenia Gravis{{c1::Cholinesterase inhibitors (e.g. pyridostigmine)}}{{c1::Oral prednisolone (to achieve remission)}}{{c1:…
Published	02/10/2024	Disease Modification of Myasthenia Gravis by usage of {{c1::Immunoglobulin}} and {{c1::Plasma exchange}}
Published	02/10/2024	Treatment of Myasthenic Crisis{{c1::Monitor respiratory function (FVC) and mechanical ventilation}}{{c1::Plasma exchange or IV Immunoglobulin}}
Status	Last Update	Fields